Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Axsome Therapeutics, Inc.
About AXSM
Axsome Therapeutics, Inc. is a fully integrated biopharmaceutical company. The Company focused on developing medicines for people impacted by central nervous system (CNS) conditions. Its commercial products include AUVELITY, SUNOSI, and SYMBRAVO. It is also advancing pipeline of novel product candidates in early- to late-stage development addressing a broad range of serious neurological and psychiatric conditions. Its product pipelines include AXS-05, AXS-12, and AXS-14. Its lead product candidate, AXS-05 (dextromethorphan-bupropion), is developed for the treatment of Alzheimer’s disease (AD) agitation and smoking cessation. Its AXS-12 (reboxetine) is a novel, oral, potent, highly selective investigational norepinephrine reuptake inhibitor (NRI) and cortical dopamine modulator being developed for the treatment of narcolepsy. Its AXS-14 (esreboxetine) is a novel, oral, potent, highly selective investigational NRI being developed for the management of fibromyalgia.
Find out what a historical investment in Axsome Therapeutics, Inc. would be worth today using our AXSM stock calculator.
Market Capitalisation
$11.66B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
646.76K
High today
$232.39
Low today
$226.50
Open price
$228.15
52-week high
$235.92
52-week low
$96.09
Ready to start your investing journey with Stake?
Open an accountHow do I buy AXSM shares in Australia?
Buying AXSM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Axsome Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AXSM
What is the ticker symbol of Axsome Therapeutics, Inc.?
The ticker symbol for Axsome Therapeutics, Inc. is AXSM.
How much is one share of AXSM?
One share of AXSM is valued at $232.00 as of 21 May 2026.
What is the market capitalisation of Axsome Therapeutics, Inc. AXSM?
As of 21 May 2026 Axsome Therapeutics, Inc. has a market cap of $11.66B.
What is the 52-week high for Axsome Therapeutics, Inc. stock?
The Axsome Therapeutics, Inc. 52-week high stock price is $235.92.
What is the 52-week low for Axsome Therapeutics, Inc. stock?
The Axsome Therapeutics, Inc. 52-week low stock price is $96.09.
Can I buy AXSM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AXSM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AXSM on Stake
- Buy AXSM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AXSM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AXSM related stocks